MEOX1: a novel druggable target that orchestrates the activation of fibroblasts in cardiac fibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1038/s41392-021-00842-7
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2021
- Urheber
-
Schumacher, David
Peisker, Fabian
Kramann, Rafael
- DOI
-
10.18154/RWTH-CONV-248165
- URN
-
urn:nbn:de:101:1-2023021100433724055003
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schumacher, David
- Peisker, Fabian
- Kramann, Rafael
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2021
Ähnliche Objekte (12)
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts
Targeting EEF1A in fibroblasts to counteract cardiac fibrosis
Myeloid-derived growth factor ameliorates cardiac fibrosis via shedding TGFBR1 in fibroblasts
Mechanical regulation of cardiac fibroblasts.
S100a4 secreted by alternatively activated alveolar macrophages promotes activation of lung fibroblasts in pulmonary fibrosis
Functional characterization and evaluation of the therapeutic potential of polo-like kinase 2 in cardiac fibroblasts and fibrosis
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Control of cardiogenesis and homeostasis by cardiac fibroblasts
Characterization Of Pirfenidone Effects In Human Cardiac Fibroblasts
The role of tubulin acetylation in cardiac fibroblasts
Repurposing mesalazine against cardiac fibrosis in vitro
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts
Targeting EEF1A in fibroblasts to counteract cardiac fibrosis
Myeloid-derived growth factor ameliorates cardiac fibrosis via shedding TGFBR1 in fibroblasts
Mechanical regulation of cardiac fibroblasts.
S100a4 secreted by alternatively activated alveolar macrophages promotes activation of lung fibroblasts in pulmonary fibrosis
Functional characterization and evaluation of the therapeutic potential of polo-like kinase 2 in cardiac fibroblasts and fibrosis
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Control of cardiogenesis and homeostasis by cardiac fibroblasts
Characterization Of Pirfenidone Effects In Human Cardiac Fibroblasts
The role of tubulin acetylation in cardiac fibroblasts
Repurposing mesalazine against cardiac fibrosis in vitro
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts
Targeting EEF1A in fibroblasts to counteract cardiac fibrosis
Myeloid-derived growth factor ameliorates cardiac fibrosis via shedding TGFBR1 in fibroblasts
Mechanical regulation of cardiac fibroblasts.
S100a4 secreted by alternatively activated alveolar macrophages promotes activation of lung fibroblasts in pulmonary fibrosis
Functional characterization and evaluation of the therapeutic potential of polo-like kinase 2 in cardiac fibroblasts and fibrosis
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Control of cardiogenesis and homeostasis by cardiac fibroblasts
Characterization Of Pirfenidone Effects In Human Cardiac Fibroblasts
The role of tubulin acetylation in cardiac fibroblasts
Repurposing mesalazine against cardiac fibrosis in vitro